Abstract -Cross-range resolution in spotlight synthetic aperture radar (SAR) is primarily a function of the angular extent (Δθ) over which data is collected. One proposed means for improving crossrange resolution for a given Δθ is the use of frequency diverse array (FDA) techniques. The goal is to exploit an apparent increase in Δθ to improve cross-range resolution while retaining benefits of shorter synthetic apertures and integration times.
INTRODUCTION
In spotlight mode synthetic aperture radar (SAR) range resolution δ y is a function of waveform bandwidth B and is given by
where c is the speed of light. Cross-range resolution is a function of wavelength λ and the angular extent of the collection Δθ (radians) and is given by
Cross-range resolution improves by either decreasing λ or increasing Δθ, e.g., an n-fold decrease in λ improves δ x by n. However, a modest improvement in δ x , say a factor of n = 2, becomes impractical due to hardware limitations and increased atmospheric attenuation at higher frequencies. Alternately, Δθ can be increased to improve cross-range resolution. This approach requires greater collection time and increases potential image smearing due to target movement and/or uncontrolled platform motion during the collection. An initial investigation considered the rangedependent characteristics of a frequency diverse array (FDA) in an attempt to increase the apparent angular extent subtended during collection. The intent was to exploit an apparent increase in Δθ to improve cross-range resolution while retaining benefits of shorter synthetic apertures and integration times. The recent emergence of FDA processing in array-based radar applications [1, 2, 3] 
(cos φ El sin θAz−cos φo sin θo) , Although an arbitrary set of frequencies can be assigned to the channels, an incremental frequency progression of Δf is used across the array elements in both the horizontal and vertical dimensions for preliminary analysis. Figure 1 shows the antenna pattern for an 9 × 1 linear FDA with a base frequency of 10 GHz, Δf = 2 kHz, and the beam steered to (
. At a range of 60 km the beam is located broadside to the array. Given that the array spatial scanning angles of
• were used, it is important to note that the range varying response is due solely to interelement frequency variation.
Given a linear array with an inter-element frequency progression of Δf and array spatial scanning angles set to 0
• , the analytic expression for mainbeam azimuth location, called the apparent scan angle θ , is a function of range R and expressed as [1] 
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Proposed Methodology
Given the range varying illumination pattern, potential benefits may be obtained by using FDA processing in SAR applications. The geometry in Fig ditional non-FDA processing, data is collected at each collection point u on the synthetic aperture of length L using a constant frequency phased array antenna. For each location u, the radar interrogates the scene at some aspect angle θ as measured from the synthetic aperture normal. By introducing FDA processing, it is envisioned that data will be collected using the resultant "bent beam" at each point along L. Thus, data collected at u is projected to an apparent collection point u app located at an apparent aspect angle θ app as illustrated. If inter-element frequency spacing Δf is adaptively varied at each collection point u, such that the FDA maintains its bent beam focused at scene center, the locus of apparent collection locations u app forms an apparent synthetic aperture with length L app . If phase can be properly accounted for when forming L app , it is surmised that the increased apparent angular extent Δθ app should lead to a corresponding improvement in cross-range resolution per (2) . At each collection point, the required frequency progression to maintain the FDA mainbeam on scene center at azimuth θ c is computed by solving (4) for Δf as follows:
To take advantage of the "bent beam" concept, the set of apparent collection points is computed. At each actual collection point u, the tangent line to the FDA beam at scene center is traced back to the synthetic aperture to locate u app . The approach for phase compensation in this initial investigation is to introduce a phase delay to compensate for additional round-trip propagation time 2Δt between u app and scene center. Time-domain correlation/backprojection is then used for image reconstruction.
RESULTS

Simulation
Simulated spotlight mode SAR processing was performed with the scenario presented in Figure 2 using the parameters shown in Table 1 . Using (1) and (2), the parameters in Table 1 Figure 3 shows the results of spotlight SAR imaging using a traditional constant frequency array. This image is consistent with expected results.
With the proposed FDA SAR approach, the apparent synthetic aperture length was found to be L app = 3, 218 m with θ app = 4.58
• . The new theoretical cross-range resolution is then δ x = 0.19 m. Figure 4 shows results using the modified FDA SAR processing. Two resulting phenomenon are immediately observed: compression and spatial aliasing in cross-range.
Analysis
The cross-range compression effect in Figure 4 is attributed to the relative simplicity of the phase mapping/compensation algorithm when translating from the original u data on physical aperture L to u app data on aperture L app . Simply incorporating a phase delay to compensate for additional propagation time to scene center did not effectively account for propagation differences to other scatterers along the radar line-of-sight.
The spatial aliasing due to under-sampling can be avoided by sampling aperture L at intervals of [4] 
where R c is the range to scene center and Δx is the width of the scene in cross-range. The image in Figure 3 was constructed using the minimum required δA. When the same δA is used in FDA SAR processing, the set of apparent collection locations u app spread over a longer aperture and result in under-sampling. Additionally, in traditional SAR imaging, the collection points are equally spaced along the synthetic aperture. This is not the case for the proposed FDA processing which uses the unequally spaced apparent collection points.
CONCLUSIONS
A priori calculation of the apparent FDA SAR length L app and resulting synthetic aperture sampling requirements can overcome the undersampling issues. Overcoming the cross-range compression issue poses a more difficult challenge and remains a subject of interest for subsequent research. Fundamentally, the FDA process only changes target illumination characteristics in the scene without altering the actual propagation time to these targets. To accurately reconstruct an image using the longer L app , each virtual range profile generated at u app must match the actual range profile at that location. Future research will investigate more accurate methods of phase mapping for translating data from original u collection points to apparent collection points at u app .
